AASLD and IDSA Announce Updates to HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
AASLD and IDSA’s HCV Guidance provides the major standards for all aspects of testing, managing, and treating hepatitis C virus (HCV). The latest changes to the guidance included recommendations for pregnant women, people who inject drugs, men who have sex with men, and people who are incarcerated.
These updates open the door to testing and treating people who have often been left out of the HCV management algorithm. The changes to the Guidance highlight the need to test and treat key at-risk populations. Hepatitis C disproportionately affects people in correctional institutions, a population that is inadequately treated. In recent years, the opioid epidemic has caused a dramatic increase in the incidence of HCV among those who inject drugs. The opioid epidemic has also led to an increased prevalence of HCV-infected women giving birth in the United States. There has also been a rise in outbreaks of sexually transmitted HCV among men who have sex with men (MSM).
To read the latest recommendations, visit HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C www.hcvguidelines.orgShare This Page